Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Avignon
Clinical trial register · France

Clinical Trials in Avignon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 64 Bordeaux 62 Montpellier 61 Lyon 60 Marseille 58
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 UNICANCER27 The Lymphoma Academic Research Organisation11 Intergroupe Francophone de Cancerologie Thoracique8 Hoffmann-La Roche7 Clear sponsor filter
Site location
Paris64 Bordeaux62 Montpellier61 Lyon60 Marseille58
All 106 locations
Target enrolment
to

Trials with a site in Avignon

27 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
AstraZeneca
Phase 3
1,100
Amiens, Avignon, Nîmes, Paris, Pau, Pierre-Bénite, Plerin SUR MER, Reims
2025-12-29
Recruiting
AstraZeneca
Phase 2
278
Avignon, Paris, Rennes, Saint-Herblain, Suresnes
2025-08-07
Recruiting
AstraZeneca
Phase 3
800
Avignon, Besançon, Bordeaux, Chambray-lès-Tours, Cholet, Créteil, Grenoble, Lille
2025-08-01
Recruiting
AstraZeneca
Phase 3
830
Angers, Avignon, Boulogne-Billancourt, Caen, Chambéry, Dijon, La Tronche, Limoges
2025-04-10
Recruiting
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
NCT06726720Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
AstraZeneca
Observational
300
Aix-en-Provence, Angers, Aurillac, Auxerre, Avignon, Bezannes, Béziers, Blois
2024-12-16
Recruiting
AstraZeneca
Phase 3
1,160
Avignon, La Rochelle, Lyon, Nîmes, Rennes, Strasbourg, Suresnes, Toulon
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Avignon, La Rochelle, Lyon, Nîmes, Rennes, Strasbourg, Suresnes, Toulon
2024-11-18
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Strasbourg, Grenoble, St-Malo, Mulhouse, Boulogne-sur-Mer, Poitiers, Avignon, Marseille
2023-12-20
Recruiting
AstraZeneca
Phase 3
1,145
Avignon, Bordeaux, Le Mans, Lyon, Nice, Saint-Herblain, Toulouse, Villejuif
2023-12-14
Active, closed
AstraZeneca
Phase 3
1,902
Avignon, Bayonne, Caen, Clermont-Ferrand, Limoges, Marseille, Montpellier, Nice
2023-11-14
Active, closed
AstraZeneca
Phase 3
895
Angers, Avignon, Bayonne, Bordeaux, Caen, Lille, Limoges, Marseille
2023-10-24
Active, closed
PRostate Olaparib Real World Evidence Study
NCT06031805Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Observational
159
Amiens, Angers, Antony, Argenteuil, Avignon, Besançon, Bordeaux, Challes-les-Eaux
2023-10-11
Recruiting
AstraZeneca
Phase 3
4,300
Angers, Argenteuil, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Cholet, Clermont-Ferrand
2023-03-31
Active, closed
AstraZeneca
Observational
254
Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Créteil, Dijon
2022-11-14
Active, closed
National Acalabrutinib Observational Study
NCT05437250Chronic Lymphocytic Leukemia
DrugNon-Interventional Study
AstraZeneca
Observational
350
Aix-en-Provence, Amiens, Angers, Ars-Laquenexy, Avignon, Besançon, Béziers, Bobigny
2022-09-13
Recruiting
AstraZeneca
Phase 2
630
Avignon, Bobigny, Bordeaux, Limoges, Rennes, Rouen, Suresnes, Toulon
2022-04-14
Active, closed
AstraZeneca
Phase 3
1,051
Avignon, Besançon, Bordeaux, Clermont-Ferrand, Créteil, Lorient, Marseille, Montpellier
2022-02-07
Active, closed
AstraZeneca
Phase 3
315
Avignon, Brest, Clermont-Ferrand, Dijon, Limoges, Lorient, Lyon, Marseille
2021-06-30
Active, closed
AstraZeneca
Observational
274
Abbeville, Aix-en-Provence, Angers, Antibes, Avignon, Bastia, Bayonne, Bordeaux
2021-05-12
Active, closed
AstraZeneca
Phase 3
1,157
Avignon, Besançon, Bordeaux, Caen, Le Mans, Montpellier, Nice, Paris
2021-04-26
Active, closed
AstraZeneca
Phase 3
358
Avignon, Bordeaux
2020-12-16
Active, closed
AstraZeneca
Phase 3
957
Avignon, Besançon, Brest, Dijon, Lyon, Montpellier, Nantes, Nice
2020-11-17
Active, closed
AstraZeneca
Phase 3
370
Avignon, Bordeaux, Clermont-Ferrand, Dijon, Lyon, Marseille, Montpellier, Strasbourg
2020-10-02
Active, closed
AstraZeneca
Phase 3
866
Avignon, Besançon, Bordeaux, Brest, Caen, Dijon, Le Mans, Marseille
2020-07-24
Active, closed
AstraZeneca
Phase 3
825
Avignon, Lyon, Nice, Toulon, Vantoux
2018-12-06
Active, closed
AstraZeneca
Phase 3
987
Avignon, Brest, Créteil, La Tronche, Pierre-Bénite, Rennes
2017-03-27
Active, closed
AstraZeneca
Phase 3
1,837
Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dechy, La Roche-sur-Yon
2014-04-22
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/avignon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Avignon that also match the filters currently applied.

How many clinical trials are recruiting in Avignon?

11 of the 27 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Avignon), 27 studies
PhaseStudiesRecruitingShare
Phase 319770.4%
Observational6222.2%
Phase 2227.4%

Most active sponsors

Lead sponsors with the most studies (Avignon)
Lead sponsorStudiesRecruiting
AstraZeneca2711
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.